Market Overview:
The global neglected tropical diseases diagnosis market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of neglected tropical diseases, rising awareness about these diseases, and technological advancements in the field of diagnostics. The global neglected tropical diseases diagnosis market is segmented by type, application, and region. By type, the market is divided into conventional method and molecular/modern method. The conventional method segment dominates the global neglected tropical diseases diagnosis market owing to its low cost and easy availability. However, with technological advancements in molecular biology techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), the molecular/modern method segment is expected to grow at a higher CAGR during the forecast period. By application, the clinical labs segment accounts for majority of share in terms of revenue followed by hospitals /clinics and home healthcare segments respectively.
Product Definition:
A Neglected Tropical Disease (NTD) is a disease that is most common in developing countries. It can often be prevented or treated with very little cost, but because it affects poor people living in remote areas, it often goes untreated. NTDs can cause blindness, disfigurement, chronic illness, and even death. The World Health Organization estimates that 1 billion people are affected by NTDs worldwide.
Conventional Method:
Conventional method, it's usage and growth factor in Neglected Tropical Diseases Diagnosis market? Isolation of causative agents by biopsy, culture or micro-organisms identification methods such as serology and immunoassays.
Isolation of causative agents by biopsy, culture or micro-organisms identification methods such as serology and immunoassays.
Molecular/Modern Method:
The global molecular/modern method and it's usage in Neglected tropical diseases diagnosis market size was valued at USD 4.2 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of NTDs, increasing demand for rapid diagnostic methods, government support for R&D activities related to NTDs are some factors attributing towards its large share globally.
Application Insights:
Based on the application, the market is segmented into clinical labs, hospitals and clinics, and home healthcare. Clinical lab held the largest share of diagnostics tests for NTDs due to high usage of these tests for diagnosis. Moreover, hospital-based laboratories also perform a significant number of diagnostic tests for NTDs as most of these diseases are highly prevalent in developing countries like India and China.
However, rising awareness about early diagnosis coupled with increasing government initiatives to control spread of disease is expected to drive growth in clinical testing segment over next few years. For instance, WHO has launched an initiative named ¢â‚¬Å“Preventive Vaccines Program¢â‚¬ which aims at preventing 10 common infectious diseases by 2020 through immunization programs; this program will focus on children population below 15 years age group across all regions including Africa & Middle East where many under-5 deaths occur due to infectious diseases every year.
Regional Analysis:
In 2017, Asia Pacific dominated the global neglected tropical diseases diagnosis market with a share of over 60%. The region is expected to maintain its position throughout the forecast period owing to increasing awareness regarding NTDs and their treatment. In addition, rising healthcare expenditure in developing economies such as India and China are anticipated to boost growth in this region.
The Latin American market for diagnostics is expected to grow at an exponential rate during the forecast period owing to several initiatives undertaken by governments of countries such as Brazil and Mexico for tackling this disease at a domestic level. For instance, in 2015-2016 season Brazilian Ministry of Health launched National Plan against NTDs which includes distribution free drugs among patients & health professionals; mass media campaigns; social mobilization activities; training/consultation programs for physicians & nurses about diagnostic tools available; etc.
Growth Factors:
- Increasing prevalence of Neglected Tropical Diseases (NTDs) across the globe.
- Rising awareness about NTDs and their diagnosis among people, especially in developing countries.
- Growing number of initiatives by governments and non-profit organizations to eradicate NTDs globally.
- Technological advancements in diagnostics for detection of NTDs at early stages
Scope Of The Report
Report Attributes
Report Details
Report Title
Neglected Tropical Diseases Diagnosis Market Research Report
By Type
Conventional Method, Molecular/Modern Method
By Application
Clinical Labs, Hospitals /Clinics, Home Healthcare
By Companies
Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Neglected Tropical Diseases Diagnosis Market Report Segments:
The global Neglected Tropical Diseases Diagnosis market is segmented on the basis of:
Types
Conventional Method, Molecular/Modern Method
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Labs, Hospitals /Clinics, Home Healthcare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Beckman Coulter/Danaher
- Bio-Rad Laboratories, Inc.
- Life Technology
- Novartis Diagnostics., Ltd.
- Ortho-Clinical Diagnostics
- Premier Medical Corporation Ltd.
- Siemens Healthcare
- Wako Chemicals, Inc.
Highlights of The Neglected Tropical Diseases Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Conventional Method
- Molecular/Modern Method
- By Application:
- Clinical Labs
- Hospitals /Clinics
- Home Healthcare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neglected Tropical Diseases Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diagnosis of neglected tropical diseases is a medical term used to describe a group of infections that are often left untreated or inadequately treated in developing countries. These infections include malaria, tuberculosis, dengue fever, and cholera.
Some of the major players in the neglected tropical diseases diagnosis market are Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc..
The neglected tropical diseases diagnosis market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neglected Tropical Diseases Diagnosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neglected Tropical Diseases Diagnosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neglected Tropical Diseases Diagnosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neglected Tropical Diseases Diagnosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neglected Tropical Diseases Diagnosis Market Size & Forecast, 2018-2028
4.5.1 Neglected Tropical Diseases Diagnosis Market Size and Y-o-Y Growth
4.5.2 Neglected Tropical Diseases Diagnosis Market Absolute $ Opportunity
Chapter 5 Global Neglected Tropical Diseases Diagnosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
5.2.1 Conventional Method
5.2.2 Molecular/Modern Method
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neglected Tropical Diseases Diagnosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
6.2.1 Clinical Labs
6.2.2 Hospitals /Clinics
6.2.3 Home Healthcare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neglected Tropical Diseases Diagnosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neglected Tropical Diseases Diagnosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neglected Tropical Diseases Diagnosis Analysis and Forecast
9.1 Introduction
9.2 North America Neglected Tropical Diseases Diagnosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
9.6.1 Conventional Method
9.6.2 Molecular/Modern Method
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
9.10.1 Clinical Labs
9.10.2 Hospitals /Clinics
9.10.3 Home Healthcare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neglected Tropical Diseases Diagnosis Analysis and Forecast
10.1 Introduction
10.2 Europe Neglected Tropical Diseases Diagnosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
10.6.1 Conventional Method
10.6.2 Molecular/Modern Method
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
10.10.1 Clinical Labs
10.10.2 Hospitals /Clinics
10.10.3 Home Healthcare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neglected Tropical Diseases Diagnosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
11.6.1 Conventional Method
11.6.2 Molecular/Modern Method
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
11.10.1 Clinical Labs
11.10.2 Hospitals /Clinics
11.10.3 Home Healthcare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neglected Tropical Diseases Diagnosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Neglected Tropical Diseases Diagnosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
12.6.1 Conventional Method
12.6.2 Molecular/Modern Method
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
12.10.1 Clinical Labs
12.10.2 Hospitals /Clinics
12.10.3 Home Healthcare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neglected Tropical Diseases Diagnosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neglected Tropical Diseases Diagnosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neglected Tropical Diseases Diagnosis Market Size Forecast by Type
13.6.1 Conventional Method
13.6.2 Molecular/Modern Method
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neglected Tropical Diseases Diagnosis Market Size Forecast by Applications
13.10.1 Clinical Labs
13.10.2 Hospitals /Clinics
13.10.3 Home Healthcare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neglected Tropical Diseases Diagnosis Market: Competitive Dashboard
14.2 Global Neglected Tropical Diseases Diagnosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Beckman Coulter/Danaher
14.3.3 Bio-Rad Laboratories, Inc.
14.3.4 Life Technology
14.3.5 Novartis Diagnostics., Ltd.
14.3.6 Ortho-Clinical Diagnostics
14.3.7 Premier Medical Corporation Ltd.
14.3.8 Siemens Healthcare
14.3.9 Wako Chemicals, Inc.
